Literature DB >> 9052889

Hypertension causes premature aging of endothelial function in humans.

S Taddei1, A Virdis, P Mattei, L Ghiadoni, C B Fasolo, I Sudano, A Salvetti.   

Abstract

We designed the present study to evaluate whether in normotensive subjects and hypertensive patients aging causes endothelial dysfunction by a defect in the L-arginine-nitric oxide pathway or production of cyclooxygenase-dependent vasoconstrictors. In 43 normotensive subjects and 47 essential hypertensive patients, we evaluated forearm blood flow (strain-gauge plethysmography) modifications evoked by intrabrachial acetylcholine (0.15, 0.45, 1.5, 4.5, and 15 microg/100 mL per minute), an endothelium-dependent vasodilator, in the presence of saline, L-arginine (1 micromol/100 mL per minute), or indomethacin (50 microg/100 mL per minute), a cyclooxygenase inhibitor, and by sodium nitroprusside (1, 2, and 4 microg/100 mL per minute), an endothelium-independent vasodilator. Vasodilation to acetylcholine was lower (P<.01) in essential hypertensive patients than normotensive control subjects, and in both groups, it declined with advancing age. In normotensive subjects older than 30 years, L-arginine potentiated the response to acetylcholine in parallel with increasing age, whereas indomethacin increased the vasodilation to acetylcholine only in the oldest group (>60 years). In younger hypertensive patients (<30 years), L-arginine but not indomethacin potentiated the response to acetylcholine. In adult patients (31 to 45 years), L-arginine still potentiated the vasodilation to acetylcholine, and indomethacin began to show some effect. In the oldest patients (46 to 60 and >60 years), L-arginine was no longer effective, and indomethacin exerted a potentiating action that was positively related to advancing age. In normotensive and hypertensive humans, similar mechanisms, including dysfunction of the nitric oxide pathway and production of cyclooxygenase-dependent vasoconstrictors, cause age-related impairment of endothelium-dependent vasodilation, and only their earlier appearance characterizes hypertensive disease. Thus, the endothelial dysfunction that occurs in hypertension seems to represent an accelerated form of dysfunction that occurs in aging.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9052889     DOI: 10.1161/01.hyp.29.3.736

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  75 in total

Review 1.  Effects of antihypertensive drugs on endothelial dysfunction: clinical implications.

Authors:  Stefano Taddei; Agostino Virdis; Lorenzo Ghiadoni; Isabella Sudano; Antonio Salvetti
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Age-related endothelial dysfunction : potential implications for pharmacotherapy.

Authors:  Rachel L Matz; Ramaroson Andriantsitohaina
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 3.  Vasoconstrictor prostanoids.

Authors:  Michel Félétou; Yu Huang; Paul M Vanhoutte
Journal:  Pflugers Arch       Date:  2010-03-24       Impact factor: 3.657

4.  Effect of age and exercise training on protein:protein interactions among eNOS and its regulatory proteins in rat aortas.

Authors:  Meredith J Luttrell; John W Seawright; Emily Wilson; Christopher R Woodman
Journal:  Eur J Appl Physiol       Date:  2013-08-31       Impact factor: 3.078

5.  Role of nitric oxide and prostanoids in the regulation of leg blood flow and blood pressure in humans with essential hypertension: effect of high-intensity aerobic training.

Authors:  Michael Nyberg; Lasse G Jensen; Pia Thaning; Ylva Hellsten; Stefan P Mortensen
Journal:  J Physiol       Date:  2012-01-23       Impact factor: 5.182

Review 6.  Essential Hypertension and Functional Microvascular Ageing.

Authors:  Rosa Maria Bruno; Stefano Masi; Marco Taddei; Stefano Taddei; Agostino Virdis
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-01-09

Review 7.  Cardiovascular risk in the metabolic syndrome: fact or fiction?

Authors:  Peter M Nilsson
Journal:  Curr Cardiol Rep       Date:  2007-11       Impact factor: 2.931

8.  Single passive leg movement assessment of vascular function: contribution of nitric oxide.

Authors:  Ryan M Broxterman; Joel D Trinity; Jayson R Gifford; Oh Sung Kwon; Andrew C Kithas; Jay R Hydren; Ashley D Nelson; David E Morgan; Jacob E Jessop; Amber D Bledsoe; Russell S Richardson
Journal:  J Appl Physiol (1985)       Date:  2017-08-31

Review 9.  Drug Treatment of Hypertension: Focus on Vascular Health.

Authors:  Alan C Cameron; Ninian N Lang; Rhian M Touyz
Journal:  Drugs       Date:  2016-10       Impact factor: 9.546

Review 10.  Endothelium-dependent contractions: when a good guy turns bad!

Authors:  Paul M Vanhoutte; Eva H C Tang
Journal:  J Physiol       Date:  2008-09-25       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.